← Evidence map

ArticlePeptides2015

ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.

Terry W Moody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25554218